Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema.

ABSTRACT:

Purpose

To evaluate long-term visual and anatomic outcomes in patients with retinal vein occlusion (RVO) treated with anti-vascular endothelial growth factor (VEGF) agents.

Design

Prospective, interventional case series.

Participants

Patients with central RVO (CRVO) or branch RVO (BRVO).

Methods

Number of anti-VEGF injections and improvement from baseline best-corrected visual acuity (BCVA) and central subfield thickness (CST) were prospectively recorded in 40 eyes of 39 CRVO patients and 50 eyes of 47 BRVO patients.

Results

Mean follow-up was 58 months for BRVO and 78 months for CRVO. Within 6 months of last follow-up, 58% of BRVO patients and 75% of CRVO patients required anti-VEGF injections to control edema. Analysis of the course of each patient ove

SUBMITTER: Iftikhar M 

PROVIDER: S-EPMC10019499 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature